1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Drug Delivery Insight 16 FEBRUARY 2015

Drug Delivery Insight 16 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - AstraZeneca Further Bolsters Respiratory Portfolio
Industry Trend Analysis - Acquisition Of Hospira Gives Pfizer Entrance To Biosimilar And Medical Device Markets
Industry Brief - Theravance/Mylan Collaboration For COPD
Industry Brief - Vectura's Chief Executive To Step Down
Industry Brief - Matinas Acquires Aquarius BioTechnologies
Industry Brief - Consort Medical Signs Long-Term Supply Deal For IDC System
Industry Brief - Gedeon Richter Enters Contraceptive Patch Agreement With Bayer
Industry Brief - Orexo Files Fentanyl Patent Litigation Against Actavis
Industry Brief - Vaxxas Raises Funds To Develop Vaccine Products Using Nanopatch Platform
Industry Brief - Medicom Opens Strategic Unit In Cambridge, UK
Industry Brief - SteadyMed Raises Funds In Equity Financing
Industry Trend Analysis - GSK's Reliance On Advair To Continue
Industry Trend Analysis - Afrezza's US Launch Will Test Appetite For New Insulin Delivery Systems
Industry Trend Analysis - Zohydro ER's Abuse-Deterrent Label Delay Will Benefit Purdue
Industry Brief - Minivelle 0.025mg Available In US For Postmenopausal Osteoporosis
Industry Brief - Covidien's Peripheral Infusion Systems Recall Marked As Class I
Industry Brief - Vogelxo Receives AB-Rating To Testim
Industry Trend Analysis - Neupro's Expansion Into China Will Boost UCB's Revenues
Industry Brief - Mast Initiates Phase IIa Studies Of AIR001 In HFpEF
Industry Brief - FF/UMEC/VI Combination Phase III Study Begins For COPD
Industry Brief - Health Canada Acceptance Of Cipher's Beteflam Patch Triggers Milestone
Industry Brief - FDA Accepts NDA For IDT's Abuse-Deterrent MorphaBond ER
Industry Brief - MiniMed 530G's Threshold Suspend Feature Reduces Nocturnal Hypoglycaemia
Industry Brief - FDA Accepts For Filing Collegium's NDA For Abuse-Deterrent Xtampza ER
Industry Brief - NanoSmart's ANA-Conjugated Liposomal Doxorubicin Gains FDA ODD For Ewing's Sarcoma

Table Of Contents

Drug Delivery Insight 16 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.